Results 171 to 180 of about 7,154 (184)

Nirmatrelvir/ritonavir and pharmacovigilance data

The International Journal of Tuberculosis and Lung Disease
S, Lassan, M, Gocova, I, Solovic, T, Tesar, Z, Motesicka, M, Lassanova   +5 more
openaire   +2 more sources

Nifedipine/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Dobutamine/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir+ritonavir/tozinameran

Reactions Weekly, 2022
openaire   +1 more source

Methylprednisolone/nirmatrelvir+ritonavir

Reactions Weekly, 2022
openaire   +1 more source

Immunosuppressants/nirmatrelvir+ritonavir

Reactions Weekly, 2022
openaire   +1 more source

Ciclosporin/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir Resistance—de Novo E166V/L50V Mutations in an Immunocompromised Patient Treated With Prolonged Nirmatrelvir/Ritonavir Monotherapy Leading to Clinical and Virological Treatment Failure—a Case Report

Clinical Infectious Diseases
Neta S Zuckerman, Tal Brosh-Nissimov, Zuckerman Neta S   +2 more
exaly  

Paxlovid (nirmatrelvir/ritonavir).

WMJ : official publication of the State Medical Society of Wisconsin, 2022
Kristin, Busse, Abir T, El-Alfy
openaire   +1 more source

Nirmatrelvir/Ritonavir/Remdesivir

Reactions Weekly
openaire   +1 more source